Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.500 | None | 0.974 | 0 | 0 | 1996 | 2018 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
group | 0.450 | None | 1.000 | 0 | 0 | 2003 | 2008 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
group | 0.450 | None | 1.000 | 0 | 0 | 2004 | 2008 | ||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
protein phosphatase, Mg2+/Mn2+ dependent 1D | 0.513 | 0.808 | 2.2E-11 |
|
group | 0.380 | None | 1.000 | 0 | 0 | 2002 | 2015 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.350 | None | 1.000 | 0 | 0 | 2010 | 2017 | ||||||||
|
prohibitin | 0.511 | 0.846 | 0.76 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 1996 | 2007 | ||||||||
|
solute carrier family 22 member 18 | 0.595 | 0.692 | 6.5E-06 |
|
group | 0.320 | None | 1.000 | 0 | 0 | 2006 | 2011 | ||||||||
|
RAD54 like | 0.633 | 0.423 | 2.4E-15 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 1997 | 1997 | ||||||||
|
N-ribosyldihydronicotinamide:quinone reductase 2 | 0.628 | 0.500 | 8.8E-07 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 1996 | 2014 | ||||||||
|
mitogen-activated protein kinase kinase kinase 1 | 0.538 | 0.731 | 1.00 |
|
group | 0.530 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
zinc finger protein 366 | 0.729 | 0.423 | 7.0E-02 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2010 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.500 | None | 0.955 | 1 | 0 | 1995 | 2018 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2020 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
group | 0.450 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
group | 0.420 | None | 0.667 | 1 | 0 | 2008 | 2016 | ||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.400 | None | 0.967 | 1 | 0 | 2001 | 2019 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2016 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
p21 (RAC1) activated kinase 1 | 0.494 | 0.808 | 1.3E-03 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2019 |